抗流感药物磷酸奥司他韦的研究进展  

Antiviral drugs oseltmnivir phosphate is reviewed

作　　者：赵冬梅[1] 潘晓娇[1] 

机构地区：[1]国家知识产权局专利局专利审查协作江苏中心,江苏苏州215011

出　　处：《医药前沿》2017年第5期5-6,共2页Journal of Frontiers of Medicine

摘　　要：流感病毒神经氨酸酶抑制剂是近些年来开发的一类重要的抗流感病毒类药物，具有抗病毒谱广、有效、耐药性低以及良好耐受性等优点。磷酸奥司他韦就是一种具代表性的流感病毒神经氨酸酶抑制剂，本文即从该药物的理化性质、作用机制、临床应用和不良反应等方面进行综述。Influenza virus neuraminidase inhibitors, a recent developed anti-influenza virus agent, and they have the advantages of broad-spectrum, highly efficiency, lower resistance, good patient tolerability against each sub-type influenza virus. Oseltamivir phosphate is a representative of these, Its physicochemical property, mechanism, clinical medication and side effects were reviewed.

关 键 词：磷酸奥司他韦 神经氨酸酶抑制剂 临床应用 不良反应 

分 类 号：R51[医药卫生—内科学]